drugset / Trial / NCT00174512

A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade

NCT00174512 ↗

Phase 1 Completed 36 enrolled Pfizer
RandomizedCrossoverOpen-labelEct

Summary

To assess the effects of GTN on QT and QTc in subjects with And without atrial pacing. This will be done with and without autonomic blockade at two different pacing rates. Moxifloxacin effect on QT and QTc will also be assessed in atrially paced patients at two different pacing rates with and without autonomic blockade

Timeline

Start
2005-03
Primary completion
—
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject GTN Unknown — —
Subject Moxifloxacin Small molecule — —

Indications

No indication recorded.